How A $200 Million Pea Protein Business Is Fueling The Ozempic Generation

February 27, 2026 - 03:14

A decades-long family endeavor has positioned a pioneering company at the forefront of a major dietary shift. What began as a modest protein powder business in the 1980s has evolved into a major agricultural technology force, now playing a pivotal role in serving the nutritional needs of a growing demographic.

The business, Puris, has become the go-to supplier for numerous national food brands racing to develop satisfying products for consumers using GLP-1 medications, such as Ozempic. These drugs, used for weight loss and diabetes, often suppress appetite, making it challenging for users to consume adequate protein through smaller meals. This creates a critical demand for high-quality, palatable protein sources that can be seamlessly incorporated into everyday foods.

Puris's specialty is transforming humble yellow peas into a versatile, neutral-tasting protein powder. This ingredient is now being integrated into everything from shakes and bars to pastas and snacks, allowing major manufacturers to improve the nutritional profile of their products without sacrificing taste. The company's success underscores a significant trend: the move toward "protein independence" by sourcing plant-based protein domestically, reducing reliance on foreign imports and building a more resilient food supply chain from American soil. With a market valuation reflecting its crucial role, this pea protein pioneer is fundamentally shaping how the nation eats in a new age of health-conscious consumption.